ProShare Advisors’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Sell
23,789
-15,470
-39% -$255K ﹤0.01% 1246
2026
Q1
$640K Buy
39,259
+18,324
+88% +$287K ﹤0.01% 943
2025
Q4
$311K Sell
20,935
-108
-0.5% -$1.53K ﹤0.01% 1439
2025
Q3
$270K Sell
21,043
-3,780
-15% -$50.4K ﹤0.01% 1504
2025
Q2
$377K Sell
24,823
-598
-2% -$9.33K ﹤0.01% 1286
2025
Q1
$425K Sell
25,421
-7,130
-22% -$131K ﹤0.01% 1188
2024
Q4
$614K Sell
32,551
-9,259
-22% -$179K ﹤0.01% 1158
2024
Q3
$786K Buy
41,810
+12,004
+40% +$230K ﹤0.01% 887
2024
Q2
$563K Sell
29,806
-9,140
-23% -$156K ﹤0.01% 920
2024
Q1
$633K Buy
38,946
+2,674
+7% +$39.1K ﹤0.01% 960
2023
Q4
$459K Buy
36,272
+6,890
+23% +$86.9K ﹤0.01% 1092
2023
Q3
$400K Sell
29,382
-772
-3% -$11.9K ﹤0.01% 1034
2023
Q2
$518K Buy
30,154
+2,134
+8% +$33.1K ﹤0.01% 932
2023
Q1
$390K Sell
28,020
-2,483
-8% -$36.5K ﹤0.01% 1044
2022
Q4
$408K Buy
30,503
+3,979
+15% +$51.4K ﹤0.01% 1066
2022
Q3
$316K Sell
26,524
-1,492
-5% -$21.2K ﹤0.01% 1121
2022
Q2
$357K Sell
28,016
-17,332
-38% -$222K ﹤0.01% 1112
2022
Q1
$586K Sell
45,348
-5,612
-11% -$74.1K ﹤0.01% 1180
2021
Q4
$807K Buy
50,960
+19,543
+62% +$334K ﹤0.01% 1158
2021
Q3
$612K Sell
31,417
-27,277
-46% -$541K ﹤0.01% 1091
2021
Q2
$1.34M Sell
58,694
-1,129
-2% -$23.4K ﹤0.01% 879
2021
Q1
$1.1M Buy
59,823
+11,296
+23% +$185K ﹤0.01% 932
2020
Q4
$723K Buy
48,527
+20,169
+71% +$263K ﹤0.01% 1039
2020
Q3
$318K Sell
28,358
-2,431
-8% -$23.9K ﹤0.01% 1141
2020
Q2
$244K Buy
+30,789
New +$255K ﹤0.01% 1349
2020
Q1
Sell
-33,235
Closed -$418K 1513
2019
Q4
$418K Buy
33,235
+4,784
+17% +$51.5K ﹤0.01% 1161
2019
Q3
$254K Buy
28,451
+1,248
+5% +$10.9K ﹤0.01% 1310
2019
Q2
$233K Sell
27,203
-604
-2% -$4.77K ﹤0.01% 1354
2019
Q1
$211K Buy
27,807
+841
+3% +$6.76K ﹤0.01% 1447
2018
Q4
$223K Sell
26,966
-2,906
-10% -$27.8K ﹤0.01% 1314
2018
Q3
$296K Sell
29,872
-3,267
-10% -$33.8K ﹤0.01% 1365
2018
Q2
$324K Buy
33,139
+1,296
+4% +$12.7K ﹤0.01% 1338
2018
Q1
$296K Sell
31,843
-4,182
-12% -$39.8K ﹤0.01% 1328
2017
Q4
$343K Buy
+36,025
New +$344K ﹤0.01% 1306
2017
Q3
Sell
-21,064
Closed -$174K 1400
2017
Q2
$174K Sell
21,064
-7,218
-26% -$54.2K ﹤0.01% 1364
2017
Q1
$203K Sell
28,282
-9,012
-24% -$65.3K ﹤0.01% 1447
2016
Q4
$266K Buy
37,294
+12,763
+52% +$88.8K ﹤0.01% 1448
2016
Q3
$178K Sell
24,531
-5,184
-17% -$33K ﹤0.01% 1361
2016
Q2
$174K Buy
29,715
+669
+2% +$4.43K ﹤0.01% 1453
2016
Q1
$185K Sell
29,046
-4,158
-13% -$22.3K ﹤0.01% 1439
2015
Q4
$213K Buy
33,204
+10,977
+49% +$68.6K ﹤0.01% 1506
2015
Q3
$129K Sell
22,227
-5,632
-20% -$41.8K ﹤0.01% 1373
2015
Q2
$243K Sell
27,859
-5,215
-16% -$43.8K ﹤0.01% 1399
2015
Q1
$264K Buy
33,074
+1,732
+6% +$12.9K ﹤0.01% 1551
2014
Q4
$243K Sell
31,342
-26,680
-46% -$195K ﹤0.01% 1650
2014
Q3
$376K Sell
58,022
-13,141
-18% -$101K 0.01% 1575
2014
Q2
$598K Sell
71,163
-20,195
-22% -$157K 0.01% 1471
2014
Q1
$613K Buy
+91,358
New +$554K 0.01% 1691
2013
Q4
Sell
-57,352
Closed -$249K 1781
2013
Q3
$249K Buy
57,352
+15,457
+37% +$70.6K 0.01% 2040
2013
Q2
$185K Buy
+41,895
New +$186K ﹤0.01% 2068

Other funds holding SEM

ProShare Advisors's SEM Position: Q2 2026 in Review

ProShare Advisors reduced its Select Medical (SEM) stake by 39% in Q2 2026, selling an estimated $255K and leaving 23,789 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #1246.

ProShare Advisors first reported a position in SEM in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.34M in Q2 2021. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • ProShare Advisors held 23,789 shares of Select Medical worth $393K as of Q2 2026.
  • ProShare Advisors sold 15,470 Select Medical shares in Q2 2026, an estimated $255K.
  • Select Medical made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1246 holding.
  • ProShare Advisors first reported a position in Select Medical in Q2 2013 and has held it in 50 quarters since.
  • ProShare Advisors's Select Medical position peaked at $1.34M in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.